Working groups

COVID-CNS has six working groups looking at specific areas linked with brain complications related to Covid-19.

Biomarkers and immunology Biomarkers and immunology

Biomarkers and immunology

Identifying immunological or brain-damage related biomarkers linked to neuropsychiatric effects of COVID-19.

Neurocognition Neurocognition

Neurocognition

Researching how COVID-19 impacts cognitive function in the brain and nervous system.

Neuroimaging Neuroimaging

Neuroimaging

Investigating the structural and functional brain changes connected with COVID-19 by analysing MRI data.

Neurology Neurology

Neurology

Evaluating neurological complications developed during the COVID-19 pandemic.

Neuropsychiatry and genomics Neuropsychiatry and genomics

Neuropsychiatry and genomics

Examining a range of psychiatric disorders as a result of COVID-19 to better understand and treat these conditions.

Neurovirology Neurovirology

Neurovirology

Comparing different neurovirulent strains of viruses linked with neurological diseases.